Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02984761 · ClinicalTrials.gov registry record · NA

Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy

A NA study of Lung Neoplasm, sponsored by VA Office of Research and Development.

Recruiting
Registry status
NA
Development phase
670
Enrollment target
17
Study locations

NCT02984761 is a NA study of Lung Neoplasm that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 670 participants, above the 472-participant average among 8 other Lung Neoplasm trials with a reported enrollment target (42% higher). The trial reports 17 study locations across 14 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02984761, a NA study of Lung Neoplasm, is actively recruiting participants, sponsored by VA Office of Research and Development.

RECRUITING
Registry status
NA
Development phase
670 participants
Enrollment target
17
Study locations

Study Summary

Patients with stage I non-small cell lung cancer have been historically treated with surgery whenever they are fit for an operation. However, an alternative treatment known as stereotactic radiotherapy now appears to offer an equally effective alternative. Doctors believe both are good treatments and are therefore conducting this study to determine if one may be possibly better than the other.

Conditions Studied

Lung Neoplasm

Interventions

  • RADIATION Stereotactic Radiotherapy
  • PROCEDURE Anatomic Pulmonary Resection

Study Locations (17)

California

  • VA Long Beach Healthcare System, Long Beach, CA - Long Beach
  • VA Greater Los Angeles Healthcare System, West Los Angeles, CA - West Los Angeles

Florida

  • Bay Pines VA Healthcare System, Pay Pines, FL - Bay Pines
  • Miami VA Healthcare System, Miami, FL - Miami

Pennsylvania

  • Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA - Philadelphia
  • VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA - Pittsburgh

Illinois

  • Edward Hines Jr. VA Hospital, Hines, IL - Hines

Indiana

  • Richard L. Roudebush VA Medical Center, Indianapolis, IN - Indianapolis

Maryland

  • Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD - Baltimore

Massachusetts

  • VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA - Boston

Michigan

  • VA Ann Arbor Healthcare System, Ann Arbor, MI - Ann Arbor

Trial Details

FieldValue
Enrollment Target 670 participants
Start Date 2017-04-13
Est. Completion 2034-03-31
Phase NA

Sponsor

VA Office of Research and Development

1,668 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02984761

The ClinicalTrials.gov registry entry for NCT02984761 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 670 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 472-participant average among 8 other Lung Neoplasm trials with a reported enrollment target (42% higher). The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Lung Neoplasm appearing as the primary indexed condition, and to 2 interventions - of which Stereotactic Radiotherapy is the first listed.

NCT02984761 reports 17 study locations spanning 14 distinct geographic areas - top geographies include California, Florida, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT02984761 about?

NCT02984761 is a clinical study titled "Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy". Patients with stage I non-small cell lung cancer have been historically treated with surgery whenever they are fit for an operation. However, an alternative treatment known as stereotactic radiotherapy now appears to offer an equally effective alternative. Doctors believe both are good treatments an...

What is the current status of trial NCT02984761?

This trial is currently recruiting. It is a NA study. The enrollment target is 670 participants. The study started on 2017-04-13. Estimated completion is 2034-03-31.

What conditions does trial NCT02984761 study?

This clinical trial studies the following conditions: Lung Neoplasm.

What interventions are being tested in trial NCT02984761?

The interventions under investigation include: Stereotactic Radiotherapy (RADIATION), Anatomic Pulmonary Resection (PROCEDURE).

Who is sponsoring clinical trial NCT02984761?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02984761 being conducted?

This trial has 17 study locations across California, Florida, Illinois, Indiana, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Lung Neoplasm

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Lung Neoplasm

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.